Papers › leukemia › 4537801

Pharmacological and protein profiling suggest venetoclax (ABT-199) as optimal partner with ibrutinib in chronic lymphocytic leukemia

Clinical cancer research : an official journal of the American Association for Cancer Research · 15-8-2015 · 4537801 on PMC →

216 citations FWCI 16.09 Chronic Lymphocytic Leukemia Research Read PDF → Trend

Citation data as of 2026-04-12 (OpenAlex).

Extracted findings

This paper hasn't been extracted into the knowledge graph yet. We're working through the corpus — 4537801 is in the queue.

In the meantime: Browse leukemia papers → · Ask about this topic → · Explore the graph →